{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:59:27Z","timestamp":1793314767544,"version":"4.5.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>This study was conducted to understand the impact of package insert (PI) revision in Japan on 18 June 2019 to allow metformin use for patients with moderately decreased kidney function (30\u2009\u2264\u2009estimated glomerular filtration rate (eGFR)\u2009&amp;lt;\u200960\u2009mL\/min\/1.73\u2009m<jats:sup>2<\/jats:sup>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A new user cohort design was employed to examine the prescription trend and the occurrence of lactic acidosis in patients prescribed metformin before and after PI revision using the Medical Information Database Network (MID-NET<jats:sup>\u00ae<\/jats:sup>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 12 May 2016 to 31 March 2020, 5,874 patients (before, <jats:italic>n<\/jats:italic> =\u20094,702; after, <jats:italic>n<\/jats:italic> =\u20091,172) were identified as new metformin users, including 1,145 patients (before, <jats:italic>n<\/jats:italic> =\u2009914; after, <jats:italic>n<\/jats:italic> =\u2009231) with moderately decreased kidney function. Although no marked changes in metformin prescription were observed before and after PI revision, the daily metformin dose at the first prescription decreased after PI revision. For both before and after PI revision, less than 10 cases of lactic acidosis occurred in all patients prescribed metformin, and no lactic acidosis was observed in patients with moderately decreased kidney function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this study are useful for understanding the safety of metformin use in patients with decreased kidney function and suggest no worse impacts of PI revision in Japan, indicating no further safety concerns on metformin use in patients with moderately decreased kidney function under the situation with careful use and safety monitoring of metformin.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1294696","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T04:34:28Z","timestamp":1706070868000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with moderately decreased kidney function based on real-world data from MID-NET\u00ae in Japan"],"prefix":"10.3389","volume":"10","author":[{"given":"Takashi","family":"Waki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Maniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyotaka","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Uyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2337\/dc17-2231","article-title":"Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4","volume":"41","author":"Lalau","year":"2018","journal-title":"Diabetes Care"},{"key":"ref2","volume-title":"404 diabetes mellitus: managment and therapies","author":"Powers","year":"2022"},{"key":"ref3","year":"2019"},{"key":"ref4","year":"2016"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.2337\/dc13-3023","article-title":"Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study","volume":"37","author":"Eppenga","year":"2014","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-associated lactic acidosis: current perspectives on causes and risk","volume":"65","author":"Defronzo","year":"2016","journal-title":"Metabolism"},{"key":"ref7","year":"2016"},{"key":"ref8","year":"2019"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/pds.4777","article-title":"The utilization and challenges of Japan\u2019s mid-net\u00ae medical information database network in post-marketing drug safety assessments: a summary of pilot pharmacoepidemiological studies","volume":"28","author":"Yamada","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/pds.4879","article-title":"Establishment of the mid-net\u00ae medical information database network as a reliable and valuable database for drug safety assessments in Japan","volume":"28","author":"Yamaguchi","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref11","year":"2020"},{"key":"ref12","year":""},{"key":"ref13","year":"2016"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/jdi.13636","article-title":"Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type\u20092 diabetes in Japan","volume":"13","author":"Bouchi","year":"2022","journal-title":"J Diabetes Investig"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13340-020-00439-5","article-title":"Japanese clinical practice guideline for diabetes 2019","volume":"11","author":"Araki","year":"2020","journal-title":"Diabetol Int"},{"key":"ref16","year":"2023"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e001279","DOI":"10.1136\/bmjdrc-2020-001279","article-title":"Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the diabetes registry Tyrol 2012-2018","volume":"8","author":"Engler","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1007\/s11606-020-06380-2","article-title":"Rates of metformin use in stage 3b chronic kidney disease rose after FDA label change","volume":"36","author":"Huang","year":"2021","journal-title":"J Gen Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/pds.4030","article-title":"Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan","volume":"25","author":"Chang","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/jamainternmed.2018.0292","article-title":"Association of Metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study","volume":"178","author":"Lazarus","year":"2018","journal-title":"JAMA Intern Med"},{"key":"ref21","year":"2002"},{"key":"ref22","year":"2023"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1294696\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T04:34:33Z","timestamp":1706070873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1294696\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":22,"alternative-id":["10.3389\/fmed.2023.1294696"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1294696","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"article-number":"1294696"}}